Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017
November 09 2017 - 8:00AM
Corium International, Inc. (NASDAQ:CORI) today announced that it
will report financial results for the fourth quarter and fiscal
year ended September 30, 2017 on Thursday, November 16, 2017
after the close of the U.S. financial markets. Corium will
host a conference call and live audio webcast at 5:00 p.m. Eastern
time, 2:00 p.m. Pacific time to discuss its
financial results and report on recent progress.
Conference Call and Webcast Details
Investors and analysts can access the call toll-free by dialing
(844) 831-3024 (United States) or +1 (315) 625-6887
(international). The conference ID# is 4879369. The
conference call will also be available via a live audio webcast
which may be accessed here, or by visiting the Investors section of
Corium's website at http://ir.coriumgroup.com/events.cfm. The
webcast will be archived on the Corium website for two weeks
following the presentation.
About Corium
Corium International, Inc. is a commercial-stage
biopharmaceutical company focused on the development, manufacture
and commercialization of specialty pharmaceutical products that
leverage the company's broad experience with advanced transdermal
and transmucosal delivery systems. Corium has multiple
proprietary programs in preclinical and clinical development,
focusing primarily on the treatment of neurological disorders, with
lead programs in Alzheimer's disease. Corium has developed
and is the sole commercial manufacturer of seven prescription drug
and consumer products with partners Mayne Pharma and Procter &
Gamble. The company has two proprietary transdermal
platforms: Corplex™ for small molecules and MicroCor®, a
biodegradable microstructure technology for small molecules and
biologics, including vaccines, peptides and proteins. In
addition to its proprietary Alzheimer's program, the company's
late-stage pipeline includes a contraceptive patch co-developed
with Agile Therapeutics and additional transdermal products that
are being developed with other partners. For further
information, please visit www.coriumintl.com.
Corplex™ and MicroCor® are registered trademarks of Corium
International, Inc.
Source: Corium
Investor and Media Contact:SMP CommunicationsSusan
Pietropaolospietropaolo@bccpartners.com(201) 923-2049
CORIUM INTERNATIONAL, INC. (NASDAQ:CORI)
Historical Stock Chart
From Mar 2024 to Apr 2024
CORIUM INTERNATIONAL, INC. (NASDAQ:CORI)
Historical Stock Chart
From Apr 2023 to Apr 2024